4//SEC Filing
Cellectar Biosciences, Inc. 4
Accession 0001144204-16-137317
$CLRBCIK 0001279704operating
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 6:59 PM ET
Size
7.9 KB
Accession
0001144204-16-137317
Insider Transaction Report
Form 4
NEIS JOHN
Director
Transactions
- Purchase
Common Stock, par value $0.00001 per share
2016-11-29$1.49/sh+333,333$496,666→ 631,317 total(indirect: See Footnote) - Purchase
Series C Warrants (right to buy)
2016-11-29$0.01/sh+333,333$3,333→ 607,946 total(indirect: See Footnote)Exercise: $1.50From: 2016-11-29Exp: 2021-11-29→ Common Stock (333,333 underlying)
Footnotes (1)
- [F1]These securities are held by Venture Investors Early Stage fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership. VIESF IV GP LLC is the general partner of Venture Investors Early Stage Fund IV Limited Partnership and Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of VIESF IV GP LLC and Venture Investors LLC are made collectively by seven managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest herein.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001279704
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 6:59 PM ET
- Size
- 7.9 KB